Local estrogen biosynthesis in males and females

Endocrine-Related Cancer

Volumn 6, Issue 2, 1999, Pages 131-137

  Simpson, E ^a   Rubin, G ^a   Clyne, C ^a   Robertson, K ^a   O'Donnell, L ^a   Davis, S ^b   Jones, M ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; GLUCOSE TRANSPORTER; HYDROXYSTEROID DEHYDROGENASE; INSULIN RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PRASTERONE; PROSTAGLANDIN E2; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; BONE MINERALIZATION; BREAST CANCER; EPIPHYSIS; ESTROGEN SYNTHESIS; FEMALE; GERM CELL; HUMAN; MALE; MESENCHYME CELL; NONHUMAN; OSTEOPOROSIS; POSTMENOPAUSE; SEX DIFFERENCE; SPERMATOGENESIS; TESTIS CELL; TISSUE SPECIFICITY;

ADIPOSE TISSUE; ANIMALS; AROMATASE; BREAST NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; SPERMATOGENESIS; TESTIS;

EID: 0033013378     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060131     Document Type: Article

References (43)

1. Agarwal VR, Bulun SE, Leitch M, Rohrich R & Simpson ER 1996 Use of alternative promoters to express the aromatase cytochrome P450 (CYP 19) gene in breast adipose tissues of cancer-free and breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 3843-3849.
2. Bayard F, Clamens S, Delsol G, Blaes N, Maret A & Faye JC 1995 Oestrogen biosynthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. Ciba Foundation Symposia 191 122-132.
3. Bruch HR, Wolf L, Budde R, Romalo G & Schweikert HU 1992 Androstenedione metabolism in cultured human osteoblast-like cells. Journal of Clinical Endocrinology and Metabolism 75 101-105.
4. Bruning PF, Bonfrer JMG, van Noord PAH, Hart AAM, de Jong-Bakker M & Nooijen WJ 1992 Insulin resistance and breast-cancer risk. International Journal of Cancer 52 511-516.
5. Bulun SE & Simpson ER 1994 Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. Journal of Clinical Endocrinology and Metabolism 78 428-432.
6. Carani C, Qin K, Simoni M, Fanstini-Fustini M, Serpanti S, Boyd J, Korach K & Simpson ER 1997 Aromatase deficiency in the male: effect of testosteone and estradiol treatment. New England Journal of Medicine 337 91-95.
7. Collaborative group on hormonal factors in breast cancer 1997 Collaborative re-analysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108441 women without breast cancer. Lancet 350 1047-1059.
8. Corbould AM, Judd SJ & Rodgers RJ 1998 Expression of types 1, 2 and 3. 17 Beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. Journal of Clinical Endocrinology and Metabolism 83 187-194.
9. Davis SR, McCloud PI, Strauss BJG & Burger HG 1995 Testosterone enhances estradiol's effects on post-menopausal bone density and sexuality. Maturitas 21 227-236.
10. Fisher CR, Graves KH, Parlow AS & Simpson ER 1998 Characterization of mice deficient in aromatase (ArKO) due to targetted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences of the USA 95 6965-6970.
11. Harris RE, Nauboodim KK & Farrar WB 1996 Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology 1 203-205.
12. Hemsell DL, Grodin JM, Brenner PF, Siiteri PK & MacDonald PC 1974 Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. Journal of Clinical Endocrinology and Metabolism 38 476-479.
13. Hotamisligil GS, Shargil NS & Spiegleman BM 1993 Adipose expression of tumor necrosis factor α: direct role in obesity-linked insulin resistance. Science 259 87-91.
14. Huang Z, Hankinson SE, Colditz GA, Stampfner MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE & Willett WC 1997 Dual effects of weight and weight gain on breast cancer risk. JAMA 278 1407-1411.
15. Jakob F, Hormann D, Seufert J, Schneider D & Kohrle J 1995 Expression and regulation of aromatase cytochrome P450 in THP-1 human myeloid leukemia cells. Molecular and Cellular Endocrinology 110 27-33.
16. Labrie F, Belanger A, Cusan L & Candas B 1997a Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Journal of Clinical Endocrinology and Metabolism 82 2403-2409.
17. Labrie F, Belanger A, Cusan L, Gomez JL & Candas B 1997b Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Journal of Clinical Endocrinology and Metabolism 82 2396-2402.
18. Labrie F, Belanger A, Luu-The V, Labrie C, Simond J, Cusan L, Gomez JL & Candas B 1998 DHEA and the intracine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 63 322-328.
19. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proceedings of the National Academy of Sciences of the USA 90 11162-11166.
20. Melton LJ 1997 Epidemiology of spinal osteoporosis. Spine 22 2S-11S.
21. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 80 3689-3698.
22. Murakami H, Sasano H, Satoh A, Satomi S, Nagura H & Harada N 1998 Aromatase in human aortic tissue. 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, USA p212 (Abstract).
23. Naftolin F, Ryan KJ, Davies IJ, Reddy VV, Flores F, Petro Z, Kuhn M, White RJ, Takaoka Y & Wolin L 1975 The formation of estrogens by central neuroendocrine tissues. Recent Progress in Hormone Research 31 295-319.
24. Nitta H, Bunick D, Hess RA, Janulis L, Newton SC, Millette CF, Osawa Y, Shizuta Y, Toda K & Bahr JM 1993 Germ cells of the mouse testis express P450 aromatase. Endocrinology 132 1396-1401.
25. Oz OK, Fisher CR, Graves KN, Nanu L, Zerwekh J & Simpson ER 1998 Alterations in bone histomorphometry and growth in aromatase deficient (ArKO) mice. 80th Annual Meeting of the Endocrine Society, New Orleans, LA, USA p61 (Abstract).
26. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, De la Londe L, Talbi M & Maloche C 1996 Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 1460-1464.
27. Raisz LG, Wiita B & Artis A 1995 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 81 37-43.
28. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H 1996 Aromatase and 17β-hydroxysteroid dehydrogenase Type 1 in human breast carcinoma. Journal of Clinical Endocrinology and Metabolism 81 4042-4046.
29. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O & Harada N 1997 Aromatase in human bone tissue. Journal of Bone and Mineral Research 12 1416-1423.
30. Service RF 1998 New role for estrogen in cancer? Science 279 1631-1633.
31. Shozu M & Simpson ER 1998 Aromatase expression of human osteoblast-like cells. Molecular and Cellular Endocrinology 139 117-129.
32. Shozu M, Zhao Y & Simpson ER 1997 Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene. Endocrinology 138 5125-5135.
33. Siiteri PK & MacDonald PC 1973 Role of extraglandular estrogen in human endocrinology. In Handbook of Physiology, Vol 2, pp 619-629. Eds RO Creep & EB Astwood. Washington DC, USA: American Physiological Society.
34. Simpson ER & Davis SR 1998 Why do the clinical sequelae of estrogen deficiency affect women more frequently than men? Journal of Clinical Endocrinology and Metabolism 83 2214.
35. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR & Mendelson CR 1997 Aromatase expression in health and disease. Recent Progress in Hormone Research 52 185-213.
36. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB & Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 331 1056-1061.
37. Spiegelman BM 1998 PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47 507-514.
38. Tsai-Morris CH, Aquilana DR & Dufau ML 1985 Cellular localization of rat testicular aromatase activity during development. Endocrinology 116 38-46.
39. Uysal KT, Wiesbrock SM, Marino MW & Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNFa function. Nature 389 610-614.
40. Yaffe K, Sawaya G, Lieberburg L & Grady D 1998 Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279 688-695.
41. Zhao Y, Nichols JE, Bulun SE, Mendelson CR & Simpson ER 1995 Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter. Journal of Biological Chemistry 270 16449-16457.
42. Zhao Y, Nichols JE, Valdez R, Mendelson CR & Simpson ER 1996a Tumor necrosis factor-α stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter I.4. Molecular Endocrinology 10 1350-1357.
43. 2 via cyclic AMP, leading to activation of promoter II of the CYP 19 (aromatase gene). Endocrinology 150 S51-S57.